Polo-like kinase 1 (PLK1) signaling in cancer and beyond
S Iliaki, R Beyaert, IS Afonina - Biochemical pharmacology, 2021 - Elsevier
PLK1 is an evolutionary conserved Ser/Thr kinase that is best known for its role in cell cycle
regulation and is expressed predominantly during the G2/S and M phase of the cell cycle …
regulation and is expressed predominantly during the G2/S and M phase of the cell cycle …
Polo-like kinase 1 inhibitors in human cancer therapy: development and therapeutic potential
Polo-like kinase 1 (PLK1) plays an important role in a variety of cellular functions, including
the regulation of mitosis, DNA replication, autophagy, and the epithelial–mesenchymal …
the regulation of mitosis, DNA replication, autophagy, and the epithelial–mesenchymal …
Lead bioactive compounds of Aloe vera as potential anticancer agent
Abstract Aloe vera (Aloe barbadensis Miller) is a perennial succulent medicinal plant. It has
been used as a traditional or folk medicine for thousands of years and claimed that it …
been used as a traditional or folk medicine for thousands of years and claimed that it …
Targeting AKT/PKB to improve treatment outcomes for solid tumors
The serine/threonine kinase AKT, also known as protein kinase B (PKB), is the major
substrate to phosphoinositide 3-kinase (PI3K) and consists of three paralogs: AKT1 (PKBα) …
substrate to phosphoinositide 3-kinase (PI3K) and consists of three paralogs: AKT1 (PKBα) …
[HTML][HTML] Typical phthalic acid esters induce apoptosis by regulating the PI3K/Akt/Bcl-2 signaling pathway in rat insulinoma cells
Abstract Di-(2-ethylhexyl) phthalate (DEHP) and dibutyl phthalate (DBP) are representative
phthalic acid esters (PAEs), a class of environmental endocrine disruptors used as …
phthalic acid esters (PAEs), a class of environmental endocrine disruptors used as …
Phosphoinositide 3-kinase signaling pathway in pancreatic ductal adenocarcinoma progression, pathogenesis, and therapeutics
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …
Polo-like kinase 4 mediates epithelial–mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway
X Tian, D Zhou, L Chen, Y Tian, B Zhong, Y Cao… - Cell death & …, 2018 - nature.com
Neuroblastoma (NB) is the most common malignant tumor in infancy and most common
extracranial solid tumor in childhood. With the improvement of diagnosis and treatment, the …
extracranial solid tumor in childhood. With the improvement of diagnosis and treatment, the …
Resistance to gemcitabine in pancreatic ductal adenocarcinoma: A physiopathologic and pharmacologic review
T Koltai, SJ Reshkin, TMA Carvalho, D Di Molfetta… - Cancers, 2022 - mdpi.com
Simple Summary PDAC is one of the most malignant tumors and its treatment, whether
surgery or chemotherapy, has shown poor results. Resistance to gemcitabine and other …
surgery or chemotherapy, has shown poor results. Resistance to gemcitabine and other …
A phase I study of dinaciclib in combination with MK‐2206 in patients with advanced pancreatic cancer
AG Murphy, M Zahurak, M Shah… - Clinical and …, 2020 - Wiley Online Library
The combination of drugs targeting Ral and PI3K/AKT signaling has antitumor efficacy in
preclinical models of pancreatic cancer. We combined dinaciclib (small molecule cyclin …
preclinical models of pancreatic cancer. We combined dinaciclib (small molecule cyclin …
Mg2+‐mediated autophagy‐dependent polarization of macrophages mediates the osteogenesis of bone marrow stromal stem cells by interfering with macrophage …
Y Zhu, S Zhao, L Cheng, Z Lin, M Zeng… - Journal of …, 2022 - Wiley Online Library
Abstract Magnesium ion (Mg2+) has received increased attention due to the roles it plays in
promoting osteogenesis and preventing inflammation. This study was designed to …
promoting osteogenesis and preventing inflammation. This study was designed to …